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Objective: The objective of this article is to evaluate the incidence of reoperation
and the associated risk and survival after primary repair of congenital heart defects
using cardiopulmonary bypass in children.
Methods: We present a retrospective analysis of 1220 consecutive children under 16
years [649 (53%) under 1 year] operated on between 1976 and 2001 by 1 surgeon
(J.L.M.).
Results: The early (30-day) mortality was 6.9%; 171 patients had 206 reoperations.
The early mortality for the first reoperation was 10.4% and for second reoperation,
3.8%. Of the first-time reoperations 63% were inevitable, 15% were planned, and
22% were unexpected. The overall 20-year freedom from reoperation was 83% and
survival (including early mortality) was 86%. The 10-year freedom from reopera-
tion and survival, respectively, was as follows: aortic valvotomy, 77% and 92%;
pulmonary valvotomy, 90% and 95%; atrial septal defect, 99% and 100%; partial
atrioventricular septal defect (AVSD), 81% and 94%; complete AVSD, 74% and
70%; VSD, 95% and 97%; double-outlet right ventricle, 66% and 68%; truncus
arteriosus, 54% and 71%; Mustard, 85% and 86%; arterial switch, 78% and 74%;
Fontan, 77% and 66%; Fallot, 91% and 93%; and total anomalous pulmonary
venous drainage, 89% and 84%. Of those undergoing aortic valvotomy, 53% were
infants, but when aortic valve replacement became necessary an adult valve could
be inserted. Introduction of the total cavopulmonary connection to the Fontan
procedure in 1990 with prior cavopulmonary anastomoses has greatly improved
outcome, with only 1 reoperation and no deaths since then. Patients with AVSD
required 12 reoperations for mitral regurgitation, mostly through the “cleft,” the
closure of which in the past 5 years has provided promising results.
Conclusions: The majority of reoperations after repair of congenital heart defects in
children are inevitable, and their incidence varies for different types of procedures.
These findings will help in informing parents about the possible outcome of surgery,
but the introduction of newer techniques may reduce the need for reoperation
further. The survival is encouraging.
Although results of surgery for congenital heart disease are nowgood, apart from some simpler conditions, for example, atrial(ASD) and ventricular septal defect (VSD), it has become appar-ent that many children may require further surgery. Therefore, todescribe the initial operation as a “repair” rather than correctionseems to be appropriate.
Increasingly, parents need more information about the operations their children
are to undergo, not only the immediate risks but also the long-term prospects
including the need for further intervention.
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The main purpose of this study was to determine how
many patients require reoperation, when, why, and the out-
come. The reasons for reoperation are classified into
planned, inevitable, and unexpected. As surgeons, we prob-
ably cannot do much about the inevitable group, but we
must try to minimize the unexpected group.
Methods
Study Population
Southampton covers a circumscribed area in the south of England
with a population of about 3 to 4 million. Virtually all children
within this area would come to this unit, although some patients
come from further afield and from abroad.
Between 1976 and 2001, a total of 1220 consecutive children
(mean age 32.2  34.5 months, range 1 day to 15 years) had a
first-time cardiac operation with cardiopulmonary bypass (CPB)
performed or supervised by 1 surgeon (J.L.M.). There were 581
girls (48%) and 639 boys (52%) with a mean age of 32.2  34.5
months (range 1 day to 16 years). Of these patients, 649 (53%)
were infants (up to 1 year old).
Patient Demographics
Data on early (30-day) death and the incidence of reoperation were
collected retrospectively from the department’s computerized da-
tabase. Patients who had had previous surgery without the use of
CPB were included, but patients who had had a previous CPB
operation elsewhere or by the principal surgeon before 1976 were
excluded. Patients were grouped according to their first operation
on bypass, and “miscellaneous” was defined as those groups with
less than 15 patients (appendix).
Technical Considerations
All operations (apart from a few ASDs closed through the right
side of the chest) were performed through the midline. For the first
15 years of this series the great majority of infants were operated
on with the use of deep hypothermia and circulatory arrest. This
has become increasingly infrequent and now circulatory arrest
would be used only for short periods, for example, in repair of an
interrupted aortic arch. Otherwise, standard CPB techniques were
used with membrane oxygenators since 1987. Crystalloid cardio-
plegia has been used since 1978 and cold blood cardioplegia for
the past 7 years. Standard operative procedures were used as
previously described.1-4
Reoperations
Reoperations were considered to be those requiring CPB. They
could be classified into the following groups:
1. Planned, where the reoperation was a staged part of a
planned strategy (eg, a Fontan-type procedure after a previ-
ous cavopulmonary anastomosis).
2. Inevitable, where it is known that the initial operation is part
of a progressive disease process (eg, late valve replacement
after aortic valvotomy or right ventricular outflow tract con-
duit replacement).
3. Unexpected, which included any reoperation performed
within 30 days or ones that could not be predicted and one
would hope would not happen (eg, closure of a residual
VSD, or repair of pulmonary artery stenosis after a switch
procedure for transposition of the great arteries [TGA]).
Follow-up
Patients were followed up by the pediatric cardiologists, both in
the main unit and in peripheral clinics. If all was well, patients with
the simplest conditions such as ASDs and VSDs would be dis-
charged. All others would be continually observed, and, if patients
were well, with increasing intervals between appointments. Fol-
low-up of the patients has therefore been obtained by contacting
the pediatric cardiologists, other physicians, or the patient‘s gen-
eral practitioner. With the exception of 3 cases, we performed all
the reoperations.
Statistics
Continuous variables are expressed as means  SD and propor-
tions as percentages. Freedom from reoperation and survival
(SEM) were calculated by the product-limit method of Kaplan
and Meier and include both early mortality and reoperations per-
formed within the same hospital admission after the initial repair.
Statistical analysis was done with the statistical package SPSS PC
(version 8.0; SPSS Inc, Chicago, Ill).
Results
There have been 85 early deaths, giving an overall operative
mortality of 6.9%. Sixty-eight additional patients died after
their discharge from the hospital (the 20-year Kaplan-Meier
survival, including the operative mortality, being 86 1%).
Operative mortality and Kaplan-Meier 10- or 20-year sur-
vival for each procedure are shown in Table 1, together with
the number (and category) of reoperations and associated
early mortality for each condition.
A total of 171 patients underwent 1 reoperation, of which
108 were inevitable, 26 were planned, and 37 were unex-
pected. The types of unexpected reoperations and their
indications are shown in Table 2. Twenty-eight patients had
a second reoperation (21 inevitable, 2 planned, and 5 unex-
pected), 5 patients had a third operation (4 inevitable and 1
unexpected), and 2 patients had a fourth reoperation (1
inevitable and 1 unexpected). Overall early mortality at first
reoperation was 10.4% and it was 3.8% at second reopera-
tion. There have been no deaths after the third or fourth
reoperations.
Overall 20-year freedom from any reoperation was 83%
 1% and from inevitable, planned, and unexpected first
reoperation this was 88%  1%, 97%  0.5%, and 96% 
0.6%, respectively. Kaplan-Meier freedom from first reop-
eration (any type, inevitable, planned, and unexpected) for
each procedure is shown in Table 3. Freedom from a second
reoperation for all patients at 10 years was 98%  4% and
it was 97%  0.6% at 20 years.
The types of reoperations according to the original pro-
cedure are described in more detail below.
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Aortic valvotomy (62 patients; age 40 46 months); 14 had
1 reoperation and the freedom from reoperation at 10
years was 77% (Figure 1).
Subaortic stenosis (20 patients; age 96 42 months); 4 had
1 reoperation, 2 of which were for repeat resection of
subaortic stenosis.
Pulmonary valvotomy/infundibulectomy (66 patients; age 30
 29 months); 8 had 1 reoperation, 5 of which were for
recurrent pulmonary stenosis.
ASD (157 patients age; 62  35 months); 2 had 1 reopera-
tion, both unrelated to ASD closure.
Partial AVSD (40 patients; age 54  33); 8 had 1 reopera-
tion, 5 of which were for mitral valve regurgitation.
Freedom from reoperation at 10 years was 81% (Figure
2).
Complete AVSD (44 patients; age 16  16 months); 9 had
1 reoperation, 7 of which were for mitral regurgitation.
Freedom from reoperation at 10 years was 74% (Figure
2).
VSD (237 patients; age 17  18 months); 13 had 1 reop-
eration, but only 1 of them was for a recurrent VSD.
VSD and pulmonary stenosis (29 patients; age 64  52
months). There were no reoperations in this group.
Double-outlet right ventricle (25 patients; age 28  29
months); 6 had 1 reoperation, 1 of which was for a
residual VSD and 1 related to iatrogenic aortic regurgi-
tation.
Mustard procedure for TGA (56 patients; age 5.7  4.6
months); 8 had 1 reoperation, 5 of which were for en-
largement of a narrowed baffle. Freedom from reopera-
tion at 10 and 20 years was 85% (Figure 3).
Switch procedure for TGA (38 patients; age 5.7  4.6
months); 7 patients had 1 reoperation, 6 of which were for
supravalvular pulmonary artery stenosis. Freedom from
reoperation at 10 years was 78% (Figure 3). Survival of
patients undergoing Mustard and switch procedures for
TGA are shown in Figure 4.
Truncus arteriosus (28 patients; age 2.9  3 months); 14
had 1 reoperation, of which 7 were for replacement of the
homograft conduit and 4 for truncal valve replacement
(Figure 5).
TABLE 1. Early mortality, first reoperations, mortality at first reoperation, and Kaplan-Meier survival
Procedure No. Early deaths First reoperation
Death at first
reoperation
Ten year survival
(%)
Aortic valvotomy 62 2 (3.2%) 14 (I) 2 (14.2%) 92 3
Resection subaortic
stenosis
20 — 4 (I) — 100
Pulmonary valvotomy 66 3 (4.5%) 8 (7-I, I-P) — 95 2
(91 4)*
ASD closure 157 — 2 (I) — 100
Partial AVSD repair 40 — 8 (7-I, 1-U) — 94 4
Complete AVSD repair 44 8 (18%) 9 (7-I, 2-U) — 70 7
VSD closure 237 3 (1.2%) 13 (10-I, 3-U) 1 (7.7%) 97 1
(93 2)
VSD and PS 29 2 (7%) — — 93 5
DORV repair 25 5 (20%) 6 (4-I, 2-U) 1 (17%) 68 10
Truncus arteriosus repair 28 7 (25%) 13 (I) 1 (7.7%) 71 9
Mustard for TGA 56 3 (5.4%) 8 (3-I, 5-U) 1 (12.5%) 86 5
(80 5)
Switch for TGA 38 8 (21%) 7 (U) 1 (14.2%) 74 7
Fontan procedure 33 6 (18%) 8 (5-I, 1-P, 2-U) — 66 8
TOF repair 177 8 (4.5%) 19 (12-I, 7-U) 2 (10.5%) 93 2
(93 2)
PA and VSD repair 31 3 (9.7%) 5 (4-I, 1-U) — 84 7
TAPVD 32 4 (12.5%) 3 (1-P, 2-U) — 84 6
IAA repair 15 1 (6.6%) 7 (6-I, 1-U) 1 (14%) 73 11
Cavopulmonary
anastomosis
17 — 6 (5-P, 1-U) — 100
Miscellaneous 112 22 (19.6%) 31 (12-I, 16-P, 3-U) 8 (25.8%) 67 5
(64 5)
All procedures 1220 85 (6.9%) 171 (108-I, 26-P,37-U) 18 (10.4%) 88 1
ASD, Atrial septal defect; AVSD, atrioventricular septal defect; VSD, ventricular septal defect; PS, pulmonary stenosis; DORV, double-outlet right ventricle;
TGA, transposition of the great arteries; TOF, tetralogy of Fallot; PA, pulmonary atresia; TAPVD, total anomalous pulmonary venous drainage; IAA,
interrupted aortic arch; I, inevitable; P, planned; U, unexpected.
*Figures within brackets denote 20-year survival and are given if adequate number of patients (15) was followed up at 20 years.
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Fontan procedure (33 patients; age 96  39 months); 8 had
1 reoperation including removal of homografts in 3 pa-
tients. Freedom from reoperation at 10 years was 77%.
Tetralogy of Fallot (177 patients; age 18  13 months); 19
had 1 reoperation, 9 of which were for pulmonary valve
replacement for pulmonary regurgitation. One was for
closure of a recurrent VSD and aortic valve repair, and 6
were for relief of right ventricular outflow tract obstruc-
tion, 5 of whom had a postoperative right ventricular/left
ventricular pressure ratio of less than 0.5. Freedom from
reoperation was 91% at 10 years and 89% at 20 years
(Figure 6).
Pulmonary atresia and VSD (31 patients; age 44  45
months); 5 had 1 reoperation, 2 of which were for inser-
tion of a homograft into the right ventricular outflow
tract.
Total anomalous pulmonary venous drainage (32 patients;
age 6.5  6.8 months); 3 had 1 reoperation, 2 of which
were for patch enlargement of stenosed pulmonary veins.
The freedom from reoperation was 89% at 10 years.
Interrupted aortic arch (15 patients; age 2.3 3.2 months);
7 had 1 reoperation, only 1 of which was for restenosis of
the aorta.
Cavopulmonary anastomosis (17 patients; age 2.3  3.2
months); 6 had 1 reoperation, 5 of which were for
planned Fontan-type procedures.
Miscellaneous procedures (112 patients; age 43  47
months); 31 had undergone reoperation among this large
and disparate group.
Discussion
Reports of complete experience of operations for congenital
heart disease are rare,5,6 tend to be from the more recent era,
and do not have long-term follow-up. This report of 1
surgeon’s experience over a 25-year period gives an idea of
what can be expected after surgical repair. Although the
total of 1220 patients is quite large, the individual numbers
of the rarer conditions are small. Most reports of surgical
results in the literature tend to relate to the particularly good
experience of surgical teams with specific conditions.7-10
Thus, a picture is built of what is possible and therefore
what should be expected. The reality is in fact different and
if the best units reported their entire experience, the whole
picture might not be quite the same. Clearly the reasons are
multifactorial, and results should be risk-adjusted.11 That
said, the currently achieved results in many units are ex-
tremely good, even with smaller and sicker patients being
routinely operated on. This is in part due to increased
surgical skill, better myocardial protection, and an improved
understanding of anatomy and physiology. Indeed, the ad-
vances in cardiology (in particular echocardiography) and
intensive care (including support systems), in addition to the
vastly superior armamentarium of inotropic and other drugs,
have made the management of today’s postoperative pa-
tients very different from 25 years ago.
In advising parents and patients what to expect in the
way of further operations, this article gives a guide, but it
must be interpreted with care. For closure of isolated ASDs
and VSDs, the likelihood of reoperation is very small. In
fact, there was only 1 reoperation for recurrent VSD out of
237 isolated VSD closures. The remaining reoperations in
the VSD group were for unrelated factors. Thus, as the
likelihood of complications requiring further surgery is so
small, most of these patients would be discharged after 1 or
2 follow-up visits. However, virtually all other patients are
observed for reasons illustrated in this article.
Of the 108 inevitable reoperations, 11 were for conduit
replacement and 50 for valve surgery. It seems unlikely that
the need for these procedures will change much in the
future.
TABLE 2. Unexpected first reoperations (n  37)
Indication for reoperation No.
Restenosis
Relief RVOT obstruction 8
Pulmonary artery stenosis after switch
procedure
6
Mustard baffle obstruction 5
Vein stenosis in TAPVD repair 2
Stenosis after repair of interrupted aortic arch 1
Ascending aortic stenosis after switch 1
Early subaortic stenosis 1
Total 24
Technical errors
Residual VSD 2
Residual VSD and aortic regurgitation 1
New aortic regurgitation 2
ASD patch reopened after Fontan 1
Partial AVSD patch reopened 1
Stenosis of cavopulmonary anastomosis 1
Total 8
“Bailout” operations
Fontan takedown 1
Cavopulmonary anastomosis for failed Ebstein
repair
1
Shunt for failing pulmonary atresia and VSD
repair
1
Total 3
Other
Mitral valve repair after repair of complete
AVSD
1
Revision of repair of corrected TGA, pulmonary
atresia, and VSD
1
Total 2
RVOT, Right ventricular outflow tract; TAPVD, total anomalous pulmonary
venous drainage; VSD, ventricular septal defects; ASD, atrial septal defect;
AVSD, atrioventricular septal defect; TGA, transposition of the great arter-
ies.
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The number of unexpected “first reoperations” at 3.2% of
survivors was reasonably low. Sixteen of the 37 were within
30 days of the first operation. Eight of these unexpected
reoperations can be regarded as technical failures (eg, for
residual VSDs) and 3 as “bailout” operations (eg, Fontan
takedown). In 24 patients various stenoses developed (Table
TABLE 3. Kaplan-Meier 10-year freedom from reoperation (%)
Procedure No. Any reoperation
Inevitable
reoperation
Planned
reoperation
Unexpected
reoperation
Aortic valvotomy 62 77 7 77 7 100 100
Subaortic stenosis 20 76 11 76 11 100 100
Pulmonary valvotomy 66 90 4 (86 5)* 93 3 (89 4) 97 2 (97 2) 100
ASD closure 157 99 0.9 (99 0.9) 99 0.9 (99 0.9) 100 100
Partial AVSD repair 40 81 7 81 7 100 100
(1-U 10 y)
Complete AVSD repair 44 74 7 78 7 100 95 3
VSD closure 237 95 1 (94 2) 96 1 (95 2) 100 99 0.7
(99 0.7)
VSD and PS 29 100 100 100 100
DORV repair 25 66 12 79 11 100 92 5
Truncus arteriosus repair 28 54 12 54 12 100 100
Mustard for TGA 56 85 5 (85 5) 94 3 (94 3) 100 91 4
(91 4)
Switch for TGA 39 78 8 100 100 78 8
Fontan 33 77 8 84 8 100 (1-P 10 y) 93 5
TOF repair 177 91 2 (89 2) 94 2 (93 2) 100 96 1
(96 1)
PA and VSD repair 31 80 8 83 8 100 97 3
TAPVD 32 89 6 100 96 4 93 5
IAA repair 15 45 14 49 15 100 93 6
Cavopulmonary anastomosis 17 43 17 100 46 18 94 6
Miscellaneous 112 61 6 83 4 79 5 97 2
All procedures 1220 86 1 91 1 98 0.4 97 0.5
ASD, Atrial septal defect; AVSD, Atrioventricular septal defect; VSD, ventricular septal defect; PS, pulmonary stenosis; DORV, double-outlet right ventricle;
TGA, transposition of the great arteries; TOF, tetralogy of Fallot; PA, pulmonary atresia; TAPVD, total anomalous pulmonary venous drainage; IAA,
interrupted aortic arch; I, inevitable; P, planned; U, unexpected.
*Figures within brackets denote 20-year freedom from reoperation and are given if adequate number of patients (15) was followed up at 20 years.
Figure 1. Kaplan-Meier survival (interrupted line) and freedom from any reoperation (continuous line) after aortic
valvotomy.
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2) between 1 day and 7 years postoperatively and 1 patient
required mitral valve repair 7 days after repair of CAVSD.
Ideally, pulmonary artery stenosis after a switch procedure
and Mustard baffle obstruction will become less common.
Furthermore, it is perhaps unfair to include recurrent right
ventricular outflow tract reconstruction after repair of Fal-
lot’s tetralogy occurring more than a year later after a good
repair with a low postoperative right ventricular/left ven-
tricular pressure ratio in this group at all. Therefore, the
number of unexpected reoperations should fall.
Although the number of second reoperations was small,
it is gratifying that the early mortality was less than for first
reoperations and that there was no mortality for subsequent
reoperation. Clearly one of the risks at reoperation is from
bleeding when the sternum is opened. Cannulation of the
femoral artery before sternal opening has only been used
rarely (eg, when it is known that a conduit is directly behind
the sternum).
In advising parents about the likely outcome of an oper-
ation, the early mortality and late outcome are equally
Figure 2. Kaplan-Meier freedom from any reoperation after repair of partial (interrupted line) and complete
(continuous line) AVSD.
Figure 3. Kaplan-Meier freedom from any reoperation after Mustard (interrupted line) and switch (continuous line)
repair of TGA.
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important. Therefore, although this report is chiefly con-
cerned with reoperations, unlike Lange’s series,12 we have
included the early mortality. Clearly the patient who has a
suboptimal operation and dies will not have postoperative
complications requiring reoperation. Therefore, to just re-
port reoperations without the early mortality does not give
the whole picture.
Patients undergoing aortic valvotomy are almost certain
to need further surgery, and the parents should be warned
accordingly. However, the freedom from operation at 10
years in this series was 77% even though 33 (53%) of the
patients undergoing aortic valvotomy were less than 1 year
of age. Because of the good results with open surgical
valvotomy, we still opt for this mode of treatment rather
than balloon valvotomy. We suggest that this results in less
early regurgitation and, because of a precise splitting of
fused cusps, delays the eventual reoperation, at which time
an adult-size valve can usually be inserted.13 Occasionally it
is possible to perform repair rather than replacement at
reoperation.14 Although the occurrence of severe aortic re-
gurgitation in an infant is an indication for a Ross proce-
dure, none has been done in this series. When aortic valve
Figure 4. Kaplan-Meier survival after Mustard (interrupted line) and switch (continuous line) repair of TGA.
Figure 5. Kaplan-Meier survival (interrupted line) and freedom from any reoperation (continuous line) after repair
of truncus arteriosus.
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replacement has been necessary, we have favored mechan-
ical valves.15
The patients undergoing repair of PAVSD and CAVSD
had a relatively high incidence of subsequent mitral valve
regurgitation, which is related to leaving the cleft unsutured,
as recommended by Carpentier.16 We now suture it, which
should result in less late mitral regurgitation, and parents
can be advised accordingly.
The 25% mortality for truncus arteriosus compares fa-
vorably with that in the United Kingdom,17 which was 41%
between 1978 and 2000. We used large homografts when-
ever possible and the mean interval before replacement was
12.7 years.18 This compares favorably with the 6.2 years
reported by Lange and coworkers.12 In comparison, only 2
of 28 survivors after repair of pulmonary atresia and VSD
have had their homografts replaced, possibly because larger
valves were inserted.
The Mustard procedure was the treatment of choice for
TGA until about 1986 when the switch procedure was
introduced, although they overlapped for a few years. It is
an interesting example of a technique that at that time had a
low mortality but with an inevitable falloff in years to come,
being superseded by an operation that at the time had a high
mortality but ideally a trouble-free late outcome. As Figures
3 and 4 show, in this small experience, the lines have still
not met, mainly because the early experience with the
switch procedure in this series had a high mortality by
today’s standards and a relatively high incidence of pulmo-
nary artery stenosis.
Of those patients undergoing a Fontan procedure before
1990, only 26% are alive without having further surgery,
but since 1990, with the total cavopulmonary connection2
and subsequently extracardiac conduit,19 there have been no
early or late deaths among 20 patients. This is a good
example of how a planned reoperation (after a cavopulmo-
nary anastomosis) has improved survival despite increasing
the total number of operations.
In Fallot’s tetralogy we have always had a policy of
correcting rather than palliating where possible. During the
period of this study, the principal surgeon has only palliated
10 infants. It was interesting that 5 patients developed
recurrent right ventricular outflow tract obstruction (even
when the immediate postoperative right ventricular/left ven-
tricular pressure ratio was less than 0.5) and this was usually
within 2 years. However, many patients will have received
transannular patches and inevitably will have pulmonary
regurgitation, which may necessitate the insertion of a valve
in the pulmonary region in due course. However, in 89
infants among this group undergoing correction of Fallot’s
tetralogy, although 77% had a transannular patch, 95% were
free of pulmonary valve replacement 20 years later.20
The miscellaneous group is so diverse that comment is
difficult. So many complicated patients fall into this group
that it is not surprising that the mortality was high at 20%
and the reoperation rate also high at 28%.
In conclusion, although obviously the longer a group of
patients is observed, the more reoperations they will need, it
is encouraging that only 15% of operative survivors re-
quired reoperation up to 26 years postoperatively. This is
clearly dependent on the case mix but gives a good idea of
the likelihood of reoperation when it comes to giving advice
to parents. Also, some of the operations have been super-
seded or changed considerably, which ideally will result in
fewer reoperations being required in the future.
Figure 6. Kaplan-Meier survival (interrupted line) and freedom from any reoperation (continuous line) after repair
of tetralogy of Fallot.
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This study has shown that in probably less than 1% of
operations were there avoidable surgical errors resulting in
reoperation. However, errors may be concealed in the early
mortality, which is why it has also been reported here.
The overall 86% 20-year Kaplan-Meier survival in this
group is encouraging for a group containing patients oper-
ated on many years ago. The early mortality has declined so
much in most centers that the overall survival must improve,
but most patients should be observed to detect any need for
reoperation, which can be achieved with low mortality.
However, the inevitable group of reoperations will probably
not reduce much and we should continue to consider oper-
ations for congenital heart disease as repairs rather than
corrections.
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Appendix
Procedures Performed in Fewer Than 15 Patients
Mitral valve disease (repair) (10)
Pulmonary atresia with intact ventricular septum (9)
Hypoplastic heart syndrome (8)
Univentricular heart and other (13)
Aortic valve disease (aortic valve replacement) (8)
Mitral valve disease (mitral valve replacement) (8)
Major aortopulmonary collaterals with other anomalies (5)
Supravalvular aortic stenosis (5)
Absent pulmonary valve syndrome (4)
Anomalous origin of coronary arteries (4)
Hemianomalous pulmonary venous drainage (3)
Hypoplastic aortic arch (3)
Tricuspid regurgitation (including Ebstein anomaly) (5)
Cor triatriatum (3)
Other (22)
Total (111)
Discussion
Dr Marshall L. Jacobs (Philadelphia, Pa). It is a particular
pleasure for me to have the opportunity to discuss Mr Monro’s
paper, as I am one of more than a dozen members of this Asso-
ciation who had the opportunity to train with Mr Monro at the
Wessex Cardiothoracic Center in Southampton.
What has been presented here this afternoon is the product of
an archival database reflecting 25 years of experience in the
management of infants and children with congenital heart disease.
Although it was perhaps less apparent 25 years ago, the importance
of this archival process is all too apparent today. Quality assurance
and quality improvement, outcomes research in general, are mere
phrases without the discipline and the diligence to prospectively
record accurate clinical data. For his pioneering effort in this
regard with respect to congenital heart disease, Mr Monro deserves
a great deal of credit.
This analysis focuses on issues of reoperation and survival.
Entry into the overall data set required that a child underwent a
primary repair with CPB. Reoperations were assigned to 1 of 3
categories: inevitable, planned, or unexpected.
In some instances, as, for example, with respect to partial
AVSD, changes in surgical strategy led to a significant reduction
in the need for secondary operations. In other instances, such as the
move toward staging of single ventricle repairs, a strategy that
virtually ensures the need for secondary operations, resulted in a
significant survival advantage.
Mr Monro, I have a few questions:
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